← Back to patent-cliff list
Synthetic psilocybin(Ceruvia Lifesciences)
Tier C — Watch / tradeSynthetic psilocybin(Ceruvia Lifesciences)
Ceruvia Lifesciences
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：5-HT1A, 5-HT2A
Indications (approved)：Alcohol abuse, Obsessive-compulsive disorder, 头痛症
Regional status
US
Phase II
2024-08-01
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Synthetic psilocybin(Ceruvia Lifesciences)?
Approved indications include: Alcohol abuse, Obsessive-compulsive disorder, 头痛症.
When does the Synthetic psilocybin(Ceruvia Lifesciences) patent expire?
No public expiry year is available for Synthetic psilocybin(Ceruvia Lifesciences) yet; this page updates once verified.
How do I get a quote for Synthetic psilocybin(Ceruvia Lifesciences) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01